Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.
暂无分享,去创建一个
Franca Fagioli | Massimo Pinzani | F. Marra | M. Pinzani | E. Novo | M. Parola | F. Fagioli | K. Mareschi | I. Ferrero | Elena Tamagno | E. David | E. Tamagno | Erica Novo | Maurizio Parola | S. Cannito | Fabio Marra | Alessandra Caligiuri | Ezio David | A. Compagnone | Sebastiano Colombatto | Katia Mareschi | Ivana Ferrero | Davide Povero | Stefania Cannito | Claudia Paternostro | Cristiana Bertolani | Chiara Busletta | Lorenzo Valfrè di Bonzo | Alessandra Compagnone | S. Colombatto | C. Bertolani | A. Caligiuri | D. Povero | C. Busletta | C. Paternostro | L. V. Bonzo | Chiara Busletta
[1] C. Heldin,et al. c-Jun N-terminal Kinase Is Necessary for Platelet-derived Growth Factor-mediated Chemotaxis in Primary Fibroblasts* , 2006, Journal of Biological Chemistry.
[2] F. Marra,et al. Extracellular signal‐regulated kinase activation differentially regulates platelet‐derived growth factor's actions in hepatic stellate cells, and is induced by In Vivo liver injury in the rat , 1999, Hepatology.
[3] K. Iwaisako,et al. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. , 2009, Gastroenterology.
[4] S. Friedman,et al. Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.
[5] G. Bellomo,et al. HNE interacts directly with JNK isoforms in human hepatic stellate cells. , 1998, The Journal of clinical investigation.
[6] M. Karin,et al. From death receptor to reactive oxygen species and c‐Jun N‐terminal protein kinase: the receptor‐interacting protein 1 odyssey , 2007, Immunological reviews.
[7] Katsunori Yoshida,et al. Transforming growth factor-β and platelet-derived growth factor signal via c-jun N-terminal kinase- dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury , 2005 .
[8] S. Forbes,et al. Hepatic fibrogenesis: from within and outwith. , 2008, Toxicology.
[9] R. Schwabe,et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. , 2003, The Journal of clinical investigation.
[10] F. Marra,et al. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. , 2008, Molecular aspects of medicine.
[11] M. Bogoyevitch,et al. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). , 2001, The international journal of biochemistry & cell biology.
[12] Katsunori Yoshida,et al. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. , 2005, The American journal of pathology.
[13] F. Marra,et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans , 2005, Gut.
[14] F. Marra,et al. Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.
[15] L. Mazzini,et al. Bone Marrow Mesenchymal Stem Cells from Healthy Donors and Sporadic Amyotrophic Lateral Sclerosis Patients , 2008, Cell transplantation.
[16] M. Karin,et al. The control of cell motility and epithelial morphogenesis by Jun kinases. , 2004, Trends in cell biology.
[17] A. Cederbaum. Cytochrome P450 2E1‐dependent oxidant stress and upregulation of anti‐oxidant defense in liver cells , 2006, Journal of gastroenterology and hepatology.
[18] D. Brenner,et al. NADPH oxidase in the liver: defensive, offensive, or fibrogenic? , 2006, Gastroenterology.
[19] F. Marra,et al. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells , 2005, Gut.
[20] A. Vercelli,et al. Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. , 2007, Journal of hepatology.
[21] S. Milani,et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. , 1993, Gastroenterology.
[22] D. Brenner,et al. Mechanisms of Fibrogenesis , 2008, Experimental biology and medicine.
[23] R. Schwabe,et al. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. , 2010, Gastroenterology.
[24] A. Gentilini,et al. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. , 2004, Journal of hepatology.
[25] F. Bozzo,et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. , 2008, Carcinogenesis.
[26] S. Milani,et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2‐mediated mechanism , 2005, Hepatology.
[27] F. Marra,et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. , 2007, The American journal of pathology.
[28] E. Novo,et al. Redox mechanisms in hepatic chronic wound healing and fibrogenesis , 2008, Fibrogenesis & tissue repair.
[29] Roger G. Chui,et al. c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. , 2005, Blood.
[30] L. Gesualdo,et al. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. , 1989, The Journal of clinical investigation.
[31] E. Zamara,et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential , 2007, Gut.
[32] A. Diehl,et al. Epithelial‐to‐mesenchymal transitions in the liver , 2009, Hepatology.